Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

计划入组 48 人 · 首次发布于 2022 年 5 月 17 日

Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)

计划入组 25 人 · 首次发布于 2021 年 6 月 16 日

Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)

计划入组 20 人 · 首次发布于 2014 年 7 月 16 日

Doxorubicin-microneedle patch array

Doxorubicin(Adriamycin, Doxil, Myocet, Caelyx pegylated liposomal, Zolsketil pegylated liposomal, Myocet liposomal (previously Myocet), Celdoxome pegylated liposomal)

C₂₇H₂₉NO₁₁ · Rx

C213 Microneedle System

ARRAY BIOPHARMA INC.

United States

Array Digital Infrastructure

Array Biopharma Inc

United States

Medicus Pharma Receives UK Regulatory Approval to Expand Phase 2 Basal Cell Carcinoma Study

Medicus Pharma Completes Phase 2 Enrollment for Novel Microneedle Basal Cell Carcinoma Treatment

Medicus Pharma Seeks Orphan Drug Designation for SkinJect in Rare Gorlin Syndrome